Amy Schochler, DO
Family Medicine · Barling, ARNPI 1851397822
Payments from drug & device makers
Across 62 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$146
- AbbVie$119
- Novo Nordisk$112
- Abbott$74
- Amgen$66
- Exact Sciences$50
- plus $379 from 18 others
What the payments were for
- Food & beverage$946100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $146 |
| AbbVie | 7 | $119 |
| Novo Nordisk | 7 | $112 |
| Abbott | 5 | $74 |
| Amgen | 4 | $66 |
| Exact Sciences | 3 | $50 |
| Dynavax Technologies Corporation | 4 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Pfizer | 3 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| GSK | 2 | $30 |
| Organon | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Abiomed | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $11 |
| Alfasigma USA, Inc. | 1 | $11 |
How this compares
$946 in reported general payments places this provider in the 55th percentile of 1,347 family medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $798 |
| Gabapentin | 24 | $427 |
| Azelastine Hcl | 13 | $397 |
| Atorvastatin Calcium | 18 | $188 |
| Amlodipine Besylate | 19 | $171 |
| Ondansetron OdtOndansetron | 14 | $121 |
| Montelukast Sodium | 12 | $119 |
| Losartan Potassium | 11 | $82 |
| Methylprednisolone | 19 | $81 |
| Metformin Hcl | 11 | $68 |
| Tizanidine Hcl | 15 | $66 |
| Lisinopril | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Barling
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
- Landon HumphreyConway$417K
- Vonda HouchinHarrisburg$206K
- Glenn GibbonsFort Smith$179K
- Christopher BrownJonesboro$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.